Nexstim
Getting back on the front footNexstim
Terms of the rights issue announcedNexstim
Securing the commercial future of NBT in depressionNexstim
Achieving commendable outcomes in depressionNexstim
Navigating the opportunity in depressionNexstim
E-FIT stroke trial results disappointNexstim
The defining inflection point expected within three weeksNexstim
First NBT system delivered in US for Major Depression indicationNexstim
Entering the next stimulating phase